Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 Oct;33(10):1301–1302. doi: 10.1136/gut.33.10.1301

New forms of treatment for inflammatory bowel disease.

D Rachmilewitz 1
PMCID: PMC1379592  PMID: 1446848

Full text

PDF
1301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brynskov J., Freund L., Rasmussen S. N., Lauritsen K., de Muckadell O. S., Williams N., MacDonald A. S., Tanton R., Molina F., Campanini M. C. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med. 1989 Sep 28;321(13):845–850. doi: 10.1056/NEJM198909283211301. [DOI] [PubMed] [Google Scholar]
  2. Danielsson A., Hellers G., Lyrenäs E., Löfberg R., Nilsson A., Olsson O., Olsson S. A., Persson T., Salde L., Naesdal J. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol. 1987 Oct;22(8):987–992. doi: 10.3109/00365528708991947. [DOI] [PubMed] [Google Scholar]
  3. Eliakim R., Karmeli F., Razin E., Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology. 1988 Nov;95(5):1167–1172. doi: 10.1016/0016-5085(88)90346-0. [DOI] [PubMed] [Google Scholar]
  4. Ginsberg A. L., Beck L. S., McIntosh T. M., Nochomovitz L. E. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med. 1988 Feb;108(2):195–199. doi: 10.7326/0003-4819-108-2-195. [DOI] [PubMed] [Google Scholar]
  5. Kozarek R. A., Patterson D. J., Gelfand M. D., Botoman V. A., Ball T. J., Wilske K. R. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989 Mar 1;110(5):353–356. doi: 10.7326/0003-4819-110-5-353. [DOI] [PubMed] [Google Scholar]
  6. Lichtiger S., Present D. H. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet. 1990 Jul 7;336(8706):16–19. doi: 10.1016/0140-6736(90)91521-b. [DOI] [PubMed] [Google Scholar]
  7. Nielsen O. H., Ahnfelt-Rønne I. 4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl. Pharmacol Toxicol. 1988 Apr;62(4):223–226. doi: 10.1111/j.1600-0773.1988.tb01876.x. [DOI] [PubMed] [Google Scholar]
  8. Wallace J. L. Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol Pharmacol. 1988 Apr;66(4):422–425. doi: 10.1139/y88-071. [DOI] [PubMed] [Google Scholar]
  9. de Kaski M. C., Peters A. M., Lavender J. P., Hodgson H. J. Fluticasone propionate in Crohn's disease. Gut. 1991 Jun;32(6):657–661. doi: 10.1136/gut.32.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES